Healthcare
Wednesday, September 7, 2016
Senate investigations panel to probe Mylan's EpiPen pricing
WASHINGTON, Sept 7 (Reuters) - The U.S. Senate's permanent
subcommittee on investigations has decided to look into Mylan
Pharmaceuticals' pricing of the EpiPen, according to a press
release issued on Wednesday.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment